静脈内（IV）水分補給療法の世界市場

静脈内（IV）水分補給療法の世界市場は2030年までに39億米ドルに到達

2024年に26億米ドルと推定される静脈内（IV）水分補給療法の世界市場は、2024年から2030年にかけてCAGR 6.7%で成長し、2030年には39億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである免疫力増強剤は、CAGR 8.4%を記録し、分析期間終了時には16億米ドルに達すると予想されます。エネルギーブースター分野の成長率は、分析期間中CAGR 4.5％と推定されます。

米国市場は7億1,490万米ドルと推定、中国はCAGR 10.8％で成長予測

米国の静脈内（IV）水分補給療法市場は、2024年に7億1,490万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年にかけてCAGR 10.8%で推移し、2030年には8億1,710万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.2%と6.6%と予測されています。欧州では、ドイツがCAGR 4.4%で成長すると予測されています。

世界の静脈内（IV）水分補給療法市場- 主要動向と促進要因まとめ

輸液療法がヘルスケアおよびウェルネス産業で人気を集めている理由

静脈内（IV）水分補給療法市場は、急速な水分補給、ウェルネスの最適化、静脈栄養注入を必要とする治療に対する消費者の意識の高まりにより、大きな成長を遂げています。静脈内水分補給療法は、臨床環境、スポーツ回復、美容医療、ウェルネスセンターなどで使用され、必要不可欠な水分、電解質、ビタミン、薬剤を血流に直接供給し、即座に吸収され効果を発揮します。

当初は病院や救急処置室で重度の脱水症状、栄養不良、慢性疾患に使用されていたが、現在ではウェルネス・クリニック、スパ、移動式点滴サービスへと拡大し、二日酔いの解消、免疫システムの強化、アンチエイジング対策、運動能力の回復、健康全般を求める消費者に対応しています。バイオハッキング文化の台頭、有名人の推薦、ソーシャルメディアによる宣伝が、個々の健康目標に合わせたオーダーメイドの点滴の需要に拍車をかけています。

点滴製剤、携帯型注入装置、オンデマンドの水分補給サービスの進歩により、点滴水分補給療法市場は、特に消費者が予防ヘルスケア、個別化されたウェルネス・ソリューション、疲労、時差ぼけ、片頭痛、免疫サポートのための非侵襲的治療を優先するようになるにつれて、今後も拡大が続くと予想されます。

静脈内水分補給療法市場を牽引する主な動向とは？

点滴静注療法の最大の動向の1つは、移動式および在宅点滴サービスの拡大です。消費者は、免許を持つ専門家による便利な自宅での点滴治療を求めるようになっており、病院での受診を避け、快適な環境で水分補給療法を受けることができるようになっています。この動向は、特に都心部や企業のウェルネス・プログラム、コンシェルジュ医療サービスにおいて顕著です。

もう一つの大きな動向は、個別化された点滴製剤の台頭です。クリニックでは、画一的な水分補給療法ではなく、特定のニーズに合わせたビタミン、ミネラル、抗酸化物質、アミノ酸、薬剤を含むカスタマイズ点滴を提供するようになっています。AIを活用した健康評価とデジタルヘルスプラットフォームの統合も市場を形成する動向です。輸液クリニックやモバイルプロバイダーは、AI主導の診断、遠隔健康相談、ウェアラブル技術を活用して、水分補給レベル、ビタミン欠乏、代謝の健康状態を分析し、患者が最適な輸液療法を受けられるようにしています。

点滴療法のフィットネスやスポーツの回復への拡大も需要を促進しています。多くのアスリート、ジム通い、週末戦士は、筋肉の回復、持久力、運動後の水分補給を助けるために、アミノ酸、電解質、パフォーマンスを高める栄養素を注入した点滴による水分補給に注目しています。この動向により、スポーツリハビリテーションクリニックやフィットネスセンターでは、全人的回復プログラムの一環として水分補給の点滴サービスを提供しています。

さらに、再生医療やアンチエイジングへの応用が、細胞修復、認知機能、長寿をサポートすると主張するNAD+静脈内投与療法への関心を高めています。富裕層やバイオハッカーは、点滴療法をベースとしたアンチエイジング・ソリューションを選ぶ傾向が強まっており、市場のプレミアムセグメントに貢献しています。

静脈内水分補給療法市場に影響を与えている課題は何か？

静脈内水分補給療法の人気が高まっているにもかかわらず、いくつかの課題が市場拡大に影響を与えています。主な懸念事項の1つは、規制の精査とライセンシング要件です。点滴静注療法は医療行為とみなされ、多くの地域ではライセンスを持つヘルスケア専門家（看護師、医師、救急隊員）のみが合法的に点滴静注を行うことができます。FDA（米国）、MHRA（英国）、EMA（欧州）などの規制機関は、誤解を招く健康強調表示や未承認の治療を防ぐため、ウェルネスに特化した点滴クリニックの安全性、有効性、マーケティング上の主張を注意深く監視しています。

もう一つの重要な課題は、静脈内投与と潜在的な合併症に関する安全性の懸念です。点滴療法は正しく行われれば一般的に安全ですが、不適切な投与、誤った点滴の挿入、アレルギー反応、感染症などがリスクとなる可能性があります。スパやウェルネスセンターのような非医療的な環境で、適切なスクリーニングプロトコルを行わずに静脈内水分補給を受けようとする消費者は、合併症のリスクが高くなる可能性があります。

静脈内水分補給療法にかかる費用もまた、制限要因となります。ウェルネスに特化した点滴治療は通常、健康保険が適用されないため、主に高所得者が利用できる贅沢なサービスとなっています。価格は、成分や投与場所にもよるが、1回あたり100ドルから500ドルの幅があり、大衆が手ごろに利用できる価格には限界があります。

もうひとつの課題は、健康増進を目的とした静脈内水分補給療法の長期的な効果を裏付ける標準的な臨床エビデンスがなく、懐疑的であることです。病院では、急性の脱水症状、化学療法のサポート、栄養不足に対して点滴療法が行われているが、エネルギー補給、解毒、免疫強化に対する点滴の有効性については、依然として議論の余地があります。医療界では、点滴による水分補給療法が経口による水分補給や栄養補給よりも優れた効果をもたらすかどうかについて議論が続いています。

点滴静注療法市場の成長を促す要因は何か？

点滴静注療法市場の成長は、予防ヘルスケアの台頭、迅速な水分補給ソリューションに対する需要の増加、代替ウェルネス治療に対する消費者の関心の高まりなど、いくつかの要因によってもたらされます。主な促進要因の1つは、ウェルネスおよびアンチエイジング産業の拡大であり、有名人の推薦、インフルエンサーマーケティング、ソーシャルメディア動向などが、即効性のある健康・美容ソリューションとしての静脈内療法に対する消費者の好奇心を煽っています。

脱水関連疾患の増加も成長要因の一つです。熱中症、慢性偏頭痛、胃腸障害、運動による脱水などの症状により、外来患者やウェルネス環境における輸液療法の需要が高まっています。高齢者、頻繁な旅行者、慢性疾患の患者も、電解質バランスを維持するための支持療法として静脈内水分補給の恩恵を受けています。

コンシェルジュ医療やプレミアム・ヘルスケア・サービスの採用が増加していることも大きな要因です。富裕層の多くは、自宅での点滴療法、プライベート・ウェルネス・センター、豪華な保養所など、オンデマンドの個別医療サービスを好みます。このため、高級ヘルスケアの一環としてVIPウェルネス点滴を提供するコンシェルジュ点滴療法プロバイダーが台頭しています。

点滴療法の製剤の進歩も市場拡大に寄与しています。栄養カクテル点滴、アンチエイジング点滴、免疫強化点滴の導入により、消費者はより幅広い専門的な点滴治療を選択できるようになりました。個々の健康ニーズに合わせた微量栄養素を豊富に含む点滴ブレンドの開発により、さらなる普及が見込まれます。

さらに、企業のウェルネス・プログラムや職場の健康増進の取り組みでは、従業員の疲労、燃え尽き症候群、脱水による生産性の低下と闘うために、点滴による水分補給療法を取り入れるケースが増えています。一部の企業では、従業員の福利厚生の一環として現場での水分補給セッションを提供しており、市場の裾野はさらに広がっています。

点滴製剤の技術革新が進み、迅速なウェルネス・ソリューションへの需要が高まり、長寿とパフォーマンスの最適化に対する消費者の関心が高まっていることから、点滴静注療法市場は医療・非医療の両分野で着実な成長が見込まれています。安全性、規制遵守、科学的検証を優先する企業は、この進化するヘルスケアとウェルネスの情勢において競争優位に立つことができると思われます。

セグメント

サービス（免疫ブースター、エネルギーブースター、スキンケア、偏頭痛、その他）;成分（薬用、非薬用）;エンドユース（病院・クリニック、ウェルネスセンター・スパ、ホームヘルスケア、その他）

調査対象企業の例

• Baxter International
• Fresenius Kabi
• B. Braun Melsungen AG
• ICU Medical
• Grifols
• Vifor Pharma
• JW Life Science
• Amanta Healthcare
• Mobile IV Medics
• Hydration Room
• REVIV
• Hydrate IV Bar
• Prime IV Hydration
• Restore Hyper Wellness
• The Hydration Room
• IV Therapy of Houston
• IV League
• IV Doc
• IV Nutrition

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Intravenous (IV) Hydration Therapy Market to Reach US$3.9 Billion by 2030

The global market for Intravenous (IV) Hydration Therapy estimated at US$2.6 Billion in the year 2024, is expected to reach US$3.9 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Immune Boosters, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Energy Boosters segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$714.9 Million While China is Forecast to Grow at 10.8% CAGR

The Intravenous (IV) Hydration Therapy market in the U.S. is estimated at US$714.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$817.1 Million by the year 2030 trailing a CAGR of 10.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Intravenous (IV) Hydration Therapy Market - Key Trends & Drivers Summarized

Why Is IV Hydration Therapy Gaining Popularity Across Healthcare and Wellness Industries?

The intravenous (IV) hydration therapy market has seen significant growth due to rising consumer awareness about rapid rehydration, wellness optimization, and medical treatments requiring intravenous nutrient infusion. IV hydration therapy is used in clinical settings, sports recovery, aesthetic medicine, and wellness centers, providing essential fluids, electrolytes, vitamins, and medications directly into the bloodstream for immediate absorption and effectiveness.

Initially used in hospitals and emergency rooms for severe dehydration, malnutrition, and chronic illnesses, IV hydration therapy has now expanded into wellness clinics, spas, and mobile IV services, catering to consumers seeking hangover relief, immune system boosts, anti-aging solutions, athletic recovery, and general well-being. The rise of biohacking culture, celebrity endorsements, and social media promotion has fueled the demand for customized IV hydration drips tailored to individual health goals.

With advancements in IV formulations, portable infusion devices, and on-demand hydration services, the IV hydration therapy market is expected to continue expanding, especially as consumers prioritize preventive healthcare, personalized wellness solutions, and non-invasive treatments for fatigue, jet lag, migraines, and immune support.

What Are the Key Trends Driving the IV Hydration Therapy Market?

One of the biggest trends in IV hydration therapy is the expansion of mobile and home-based IV infusion services. Consumers are increasingly seeking convenient, at-home IV treatments administered by licensed professionals, allowing them to avoid hospital visits and receive hydration therapy in a comfortable setting. This trend is particularly strong in urban centers, corporate wellness programs, and concierge medicine services.

Another major trend is the rise of personalized IV formulations. Instead of one-size-fits-all hydration therapy, clinics now offer customized IV drips containing vitamins, minerals, antioxidants, amino acids, and medications tailored to specific needs. The integration of AI-powered health assessments and digital health platforms is another trend shaping the market. IV hydration clinics and mobile providers are leveraging AI-driven diagnostics, telehealth consultations, and wearable technology to analyze hydration levels, vitamin deficiencies, and metabolic health, ensuring patients receive optimal IV therapy recommendations.

The expansion of IV therapy into fitness and athletic recovery is also driving demand. Many athletes, gym-goers, and weekend warriors are turning to IV hydration drips infused with amino acids, electrolytes, and performance-enhancing nutrients to aid in muscle recovery, endurance, and post-workout rehydration. This trend has led to sports rehabilitation clinics and fitness centers offering IV hydration services as part of holistic recovery programs.

Additionally, regenerative medicine and anti-aging applications are fueling interest in NAD+ IV therapy, which claims to support cellular repair, cognitive function, and longevity. High-net-worth individuals and biohackers are increasingly opting for IV-based anti-aging solutions, contributing to the premium segment of the market.

What Challenges Are Impacting the IV Hydration Therapy Market?

Despite the growing popularity of IV hydration therapy, several challenges impact its market expansion. One of the primary concerns is regulatory scrutiny and licensing requirements. IV hydration therapy is considered a medical treatment, and in many regions, only licensed healthcare professionals (nurses, doctors, paramedics) can legally administer IV infusions. Regulatory bodies such as the FDA (U.S.), MHRA (UK), and EMA (Europe) are closely monitoring the safety, efficacy, and marketing claims of wellness-focused IV clinics to prevent misleading health claims and unapproved treatments.

Another significant challenge is safety concerns related to IV administration and potential complications. While IV therapy is generally safe when administered correctly, improper dosing, incorrect IV insertion, allergic reactions, and infections can pose risks. Consumers seeking IV hydration in non-medical settings, such as spas or wellness centers, without proper screening protocols may face higher risks of complications.

The cost of IV hydration therapy is also a limiting factor. Wellness-focused IV treatments are not typically covered by health insurance, making them a luxury service accessible primarily to high-income individuals. Prices can range from $100 to $500 per session, depending on the ingredients and administration location, which limits mass-market affordability.

Another challenge is skepticism and lack of standardized clinical evidence supporting the long-term benefits of IV hydration therapy for wellness purposes. While hospitals use IV therapy for acute dehydration, chemotherapy support, and nutrient deficiencies, the effectiveness of IV drips for energy boosts, detoxification, and immune enhancement remains controversial. The medical community continues to debate whether IV hydration therapy provides superior benefits over oral hydration and nutrition.

What Factors Are Driving the Growth of the IV Hydration Therapy Market?

The growth in the IV hydration therapy market is driven by several factors, including the rise of preventive healthcare, increasing demand for rapid hydration solutions, and growing consumer interest in alternative wellness treatments. One of the key drivers is the expanding wellness and anti-aging industry, where celebrity endorsements, influencer marketing, and social media trends have fueled consumer curiosity about IV therapy as a fast-acting health and beauty solution.

The rising prevalence of dehydration-related conditions is another growth factor. Conditions such as heat exhaustion, chronic migraines, gastrointestinal disorders, and athletic dehydration have increased the demand for IV fluid therapy in outpatient and wellness settings. Elderly populations, frequent travelers, and individuals with chronic illnesses also benefit from IV hydration as a supportive therapy for maintaining electrolyte balance.

Another major driver is the increasing adoption of concierge medicine and premium healthcare services. Many high-net-worth individuals prefer on-demand, personalized medical services, including IV therapy at home, private wellness centers, and luxury retreats. This has led to the rise of concierge IV therapy providers offering VIP wellness infusions as part of an exclusive healthcare experience.

The advancement in IV therapy formulations has also contributed to market expansion. With the introduction of IV nutrient cocktails, anti-aging infusions, and immune-boosting drips, consumers now have a wider range of specialized IV treatments to choose from. The development of micronutrient-rich IV blends tailored to individual health needs is expected to drive further adoption.

Additionally, corporate wellness programs and workplace health initiatives are increasingly incorporating IV hydration therapy to help employees combat fatigue, burnout, and dehydration-related productivity loss. Some companies are offering on-site IV hydration sessions as part of their employee wellness benefits, further broadening market reach.

With ongoing innovations in IV formulations, growing demand for rapid wellness solutions, and increasing consumer interest in longevity and performance optimization, the IV hydration therapy market is expected to experience steady growth in both medical and non-medical segments. Companies that prioritize safety, regulatory compliance, and scientific validation will gain a competitive edge in this evolving healthcare and wellness landscape.

SCOPE OF STUDY:

The report analyzes the Intravenous (IV) Hydration Therapy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service (Immune Boosters, Energy Boosters, Skin Care, Migraine, Others); Component (Medicated, Non-medicated); End-Use (Hospitals & Clinics, Wellness Centers & Spas, Home Healthcare, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Baxter International
• Fresenius Kabi
• B. Braun Melsungen AG
• ICU Medical
• Grifols
• Vifor Pharma
• JW Life Science
• Amanta Healthcare
• Mobile IV Medics
• Hydration Room
• REVIV
• Hydrate IV Bar
• Prime IV Hydration
• Restore Hyper Wellness
• The Hydration Room
• IV Therapy of Houston
• IV League
• IV Doc
• IV Nutrition

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Intravenous (IV) Hydration Therapy - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Growing Popularity of Preventive Wellness and Lifestyle Medicine Drives Demand for IV Hydration Therapy
  • Rising Incidence of Dehydration-Linked Conditions Among Elderly and Chronic Patients Expands Use Cases
  • Expansion of Mobile and On-Demand IV Therapy Services Enhances Market Accessibility
  • Surge in Health-Conscious Consumer Segments Spurs Growth in Vitamin-Infused IV Treatments
  • Increased Adoption of IV Therapy in Sports Recovery and Performance Optimization Boosts Demand
  • Rise in Beauty and Aesthetic Clinics Offering IV Drips Strengthens Wellness Market Penetration
  • Digital Booking Platforms and Telehealth Integration Enhance Consumer Engagement and Reach
  • Expansion of IV Therapy Franchises and Retail Clinics Supports Market Formalization
  • Growing Awareness of Immunity-Boosting and Anti-Aging Drips Fuels Market Interest
  • Shift Toward Personalized and Condition-Specific IV Cocktails Enhances Patient Satisfaction
  • Increased Hospital Use of IV Therapy in Emergency and Postoperative Care Sustains Core Medical Demand
  • Regulatory Clarity Around Clinical Safety and Medical Oversight Enhances Market Trust
  • Emergence of IV Hydration Subscriptions and Loyalty Programs Drives Repeat Use and Brand Retention
  • High Uptake of Hangover and Jetlag Recovery Drips Among Urban Millennials Expands Use in Leisure Segments
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Intravenous (IV) Hydration Therapy Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Intravenous (IV) Hydration Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Intravenous (IV) Hydration Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Immune Boosters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Immune Boosters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Immune Boosters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Energy Boosters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Energy Boosters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Energy Boosters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Skin Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Skin Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Skin Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Migraine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Home Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Wellness Centers & Spas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Wellness Centers & Spas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Wellness Centers & Spas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Medicated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Medicated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Medicated by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Non-medicated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Non-medicated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Non-medicated by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• JAPAN
  • Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• CHINA
  • Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 65: China Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• EUROPE
  • Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Intravenous (IV) Hydration Therapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Intravenous (IV) Hydration Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• FRANCE
  • Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 86: France Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• GERMANY
  • Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 113: UK Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Intravenous (IV) Hydration Therapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Intravenous (IV) Hydration Therapy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• INDIA
  • Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 170: India Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Intravenous (IV) Hydration Therapy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Intravenous (IV) Hydration Therapy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Intravenous (IV) Hydration Therapy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Intravenous (IV) Hydration Therapy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
• AFRICA
  • Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030

IV. COMPETITION